ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 219

DXA Body Composition, Sarcopenia and Knee and Hip Osteoarthritis: Results from the Khoala Cohort

Clémence Jeanmaire1, Isabelle Chary-Valkenaere1, Damien Loeuille2, Lorraine Bernard3 and Anne-Christine Rat,4, 1Rheumatology, CHU Nancy, Vandoeuvre Les Nancy, France, 2Rheumatology, CHU Brabois, Vandoeuvre les Nancy, France, 3CHU Nancy, Pôle S2R, Epidémiologie et Evaluation Cliniques, INSERM, CIC-EC, CIE6, Vandoeuvre Les Nancy, France, 4Université de Lorraine, Nancy, F-54000, France; Inserm, , CIC-EC, CIC 1433, Nancy, F-54000, France; CHU de Nancy, Clinical Epidemiology and Evaluation Department, Nancy, F-54000, France; CHU de Nancy, Rheumatology department, Nancy, France

Meeting: ACR/ARHP Annual Meeting 2014

Keywords: Hip, obesity, Osteoarthritis, patient outcomes and sarcopenia

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects: Imaging and Biomechanics

Session Type: Abstract Submissions (ACR)

Background/Purpose

Obesity is a well known risk factor for the development and progression of knee osteoarthritis (OA), and to a lesser extent of hip OA. However, types of obesity and body composition abnormalities could have different impact on OA severity. Body composition has rarely been studied in hip OA and has never been compared to knee OA.

The purpose of this study was to analyze the associations between body composition and sarcopenia and OA location and severity (clinical and structural), in patients with symptomatic hip and/or knee OA.

Methods

Skeletal muscle and fat mass were measured using dual X-ray absorptiometry (DXA) in a subset of patients of the Knee and Hip OsteoArthritis Long term assessment (KHOALA) cohort1.

Skeletal muscle mass index (SMI) was defined as appendicular skeletal muscle mass (ASM) / body weight. The SMI cutoff values used for sarcopenia were 26.8% for men and 21.0% for Women 2.

Pain and function were measured by WOMAC index and quality of life (QoL) by SF36. Structural severity was graded on X-Ray according to Kellgren and Lawrence‘s classification.

Percentages of patients in each group of body composition defined by presence or absence of obesity (BMI) ³ 30 kg/m2 )) and/or sarcopenia were compared in knee and/or hip OA.

We also compared severity of OA (Xrays grade, pain, function and quality of life) in each group of body composition.  

Results

A DXA was performed in 381 patients among the 878 patients included in the cohort: women 254 (66.7%), mean (STD) age 63.6 (8.4), Hip OA 91 (23.9%), knee OA 267 (70.1), obesity   146 (38.8%), sarcopenia 105 (27.6%).

Associations between joint and OA severity according to body composition group are presented in table.

 

Normal body composition

Non obese patients with sarcopenia

Obese patients without sarcopenia

Obese patients with

sarcopenia

 

N=205

N=25

N=65

N=80

N

(%)

N

(%)

N

(%)

N

(%)

p

Joint

   Hip

66

(74.1)

9

(10.1)

5

(5.6)

9

(10.1)

<0.001

   Knee

127

(48.2)

16

(6.1)

55

(20.9)

65

(24.7)

   Hip and knee

12

(52.2)

0

5

(21.7)

6

(26.1)

Kellgren stage

   2

103

(56.3)

10

(5.5)

31

(16.9)

29

(15.8)

0.05

   3

48

(52.2)

10

(10.9)

14

(15.2)

20

(21.7)

   4

34

(43.6)

4

(5.1)

18

(23.1)

22

(28.2)

SF36 PCS (mean (std))

44.3 (8.4)

39.7 (9.1)

38.7 (9.4)

38.2 (9.1)

<0.001

SF36 MCS (mean (std))

48.1 (10.5)

45.8 (10.7)

46.2 (10.7)

44.6 (11.7)

0.09

WOMAC Function (mean (std))

24.1 (17.3)

36.2 (24.3)

34.7 (21.5)

35.9 (20.5)

<0.001

WOMAC Pain  (mean (std))

27.0 (18.5)

36.8 (25.7)

38.7 (20.8)

39.6 (22.1)

<0.001

WOMAC [0,100], 0=best, 100=worse), SF36 PCS: Physical component summary, MCS: Mental component summary, 0=worse, 100=best

Normal body composition was significantly more frequent in patients with hip than knee OA, but frequency of patients with sarcopenia was not different in hip or knee OA.

Normal body composition seemed to decrease in more severe Kellgren stages but the associations did not reach statistical significance.

Physical component summary score was higher and pain score lower in patients with normal body composition than in patients with obesity. In patients with normal BMI, scores did not differ with or without sarcopenia.

Function score was lower in patients with normal body composition than in other patients. No difference was found between obese patients with or without sarcopenia.  No difference was found between patients with sarcopenia and normal BMI and obese patients. 

Conclusion

Impact of OA on pain, function and QoL was not different between obese patients and patients with sarcopenia and normal BMI. Impact of OA was worse in obese patients with or without sarcopenia than in patients with normal body composition.  

Guillemin F et al. Joint Bone Spine. 2012

Lee S et al. Arthritis and Rheumatism


Disclosure:

C. Jeanmaire,
None;

I. Chary-Valkenaere,
None;

D. Loeuille,
None;

L. Bernard,
None;

A. C. Rat,,
None.

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2014

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dxa-body-composition-sarcopenia-and-knee-and-hip-osteoarthritis-results-from-the-khoala-cohort/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology